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Obesity increases risk for liver toxicity by the anti-leukemic
agent asparaginase, but the mechanism is unknown. Asparagi-
nase activates the integrated stress response (ISR) via sensing
amino acid depletion by the eukaryotic initiation factor 2 (eIF2)
kinase GCN2. The goal of this work was to discern the impact of
obesity, alone versus alongside genetic disruption of the ISR, on
mechanisms of liver protection during chronic asparaginase
exposure in mice. Following diet-induced obesity, biochemical
analysis of livers revealed that asparaginase provoked hepatic
steatosis that coincided with activation of another eIF2 kinase
PKR-like endoplasmic reticulum kinase (PERK), a major ISR
transducer to ER stress. Genetic loss ofGcn2 intensified hepatic
PERK activation to asparaginase, yet surprisingly, mRNA levels
of key ISR gene targets such asAtf5 and Trib3 failed to increase.
Instead, mechanistic target of rapamycin complex 1 (mTORC1)
signal transduction was unleashed, and this coincided with liver
dysfunction reflected by a failure to maintain hydrogen sulfide
production or apolipoprotein B100 (ApoB100) expression. In
contrast, obese mice lacking hepatic activating transcription
factor 4 (Atf4) showed an exaggerated ISR and greater loss
of endogenous hydrogen sulfide but normal inhibition of
mTORC1 and maintenance of ApoB100 during asparaginase
exposure. In both genetic mouse models, expression and phos-
phorylation of Sestrin2, an ATF4 gene target, was increased by
asparaginase, suggesting mTORC1 inhibition during asparagi-
nase exposure is not driven via eIF2-ATF4-Sestrin2. In conclu-
sion, obesity promotes a maladaptive ISR during asparaginase
exposure. GCN2 functions to repress mTORC1 activity and
maintain ApoB100 protein levels independently of Atf4 expres-
sion, whereas hydrogen sulfide production is promoted via
GCN2-ATF4 pathway.
Asparaginase (ASNase)4 is an important drug in the treat-
ment of acute lymphoblastic leukemia in children and adults. It
functions by depleting circulating asparagine and glutamine,
essential for the growth of the leukemic lymphoblast (1).
Despite decades of clinical use, medical professionals remain
uncertain how to predict and/or prevent a range of asparagi-
nase-triggered metabolic toxicities that lead to treatment
failure (2, 3). Furthermore, the risk of asparaginase-associated
non-hematologic adverse events such as hepatotoxicity is sig-
nificantly greater in obese patients (4).
Asparaginase treatment is a form of amino acid stress that
increases phosphorylation of eukaryotic initiation factor 2
(eIF2) in liver and other tissues by general control nondere-
pressible kinase 2 (GCN2; EIF2AK4 in humans) (5, 6). GCN2 is
one of four eIF2 kinases that collectively activate a homeostatic
program coined the integrated stress response (ISR) under a
variety of stress conditions, including amino acid depletion. A
second eIF2 kinase, protein kinase R-like endoplasmic reticu-
lum kinase (PERK; EIF2AK3 in humans) is localized to the ER
and is activated upon stress in this organelle. Activation of the
integrated stress response via phosphorylation of eIF2 attenu-
ates global protein synthesis in favor of gene-specific mRNA
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translation. The best characterized translationally-induced
gene in the integrated stress response is activating transcription
factor 4 (Atf4) (7), encoding a basic leucine zipper DNA-bind-
ing protein that dimerizes with itself and/or other basic leucine
zipper transcription factors such as CCAAT/enhancer-binding
protein homologous protein (CHOP, also known as DDIT3/
GADD153) and ATF3 (8). The ATF4-directed transcriptional
response to amino acid deprivation is homeostatic and self-
limiting via induction of negative feedback regulators (9, 10).
The duration and amplitude of ATF4 expression over time
influences cellular decision making by dynamic mechanisms
that are not well understood.
Previous work from our laboratory shows that deficiency in
GCN2 predisposes to metabolic toxicities by asparaginase.
Lean Gcn2/ mice are normal and phenotypically indistin-
guishable from intact mice. However, when exposed to amino
acid depletion by asparaginase, lean Gcn2/ mice develop
metabolic complications including hepatic dysfunction and
injury, pancreatitis, and immunosuppression (6, 11–14). These
findings are consistent with clinical reports identifying and
associating specific single nucleotide polymorphisms in genes
regulated by GCN2, such as Asns and Atf5, with poorer out-
comes to asparaginase treatment (15, 16).
The objective of this investigation was to assess how met-
abolic and genetic determinants influence the hepatic ISR
during asparaginase treatment. Herein, we report that diet-
induced obesity promotes hepatic steatosis and stress during
asparaginase. The level of hepatic stress created by asparag-
inase in obese mice was further intensified in the absence
of GCN2, evidenced by premature morbidity that corre-
sponded with inappropriate phosphorylation of PERK,
hyperactivation of mechanistic target of rapamycin complex
1 (mTORC1) signaling, and a block in endogenous hydrogen
sulfide production. Additional experiments revealed that
loss of hepatic Atf4 expression reduced hydrogen sulfide
production but did not activate mTORC1 during asparagi-
nase. These data support a model where ATF4 acts to tran-
scriptionally limit ISR gene expression during amino acid
depletion, whereas GCN2 functions to inhibit mTORC1
activity. These findings provide novel insights into how
amino acid sensing pathways are altered by both metabolic
state and genetic background, influencing the hepatoprotec-
tive capacity of the integrated stress response to amino acid
depletion by asparaginase.
Results
Obesity promotes hepatic steatosis to asparaginase and
hastensmorbidity when in combinationwith Gcn2 deletion
To investigate the impact of diet-induced obesity on meta-
bolic and molecular responses to asparaginase, Gcn2/ wild
type (WT) and Gcn2/ mice were fed an obesogenic diet ad
libitum for 12 weeks. Onset of obesity was monitored by body
composition changes and development of glucose intolerance
(Fig. 1, A and B, and supplemental Fig. S1, A and B). Overall fat
accumulationwas less in theGcn2/ cohort as comparedwith
the WT strain, reaching statistical significance in the female
group only. No differences in food intake were observed
between the strains (supplemental Fig. S1C). Assessment of
glucose tolerance showed that obese males of both strains
differed significantly from their lean counterparts, whereas
females were resistant to developing glucose intolerance. Fur-
thermore, Gcn2/males cleared blood glucose slightly faster
than WT mice regardless of body composition.
Following establishment of obesity, mice were assigned to
once daily intraperitoneal injections of L-asparaginase or an
equivolume of phosphate-buffered saline as a vehicle control.
Asparaginase exposure promoted catabolism in all animals as
evidenced by loss of bodyweight (Fig. 1C, and supplemental Fig.
S2A), body fat and lean mass (supplemental Fig. S2B). Despite
weight loss, all WT mice appeared healthy and active. In con-
trast, 5 of 13 Gcn2/ animals (2 males and 3 females) devel-
opedmetabolic distress prematurely and were euthanized after
the 7th injection due to emerging morbidity. Hepatic gross
morphology of harvested livers revealed an extreme accumula-
tion of fat as evidenced by visually pale appearance (Fig. 1D),
alongside increased liver size relative to body weight (supple-
mental Fig. S1C). Hepatic fat accumulation was also confirmed
by triglyceride measurement (Fig. 1E). Abundance of hepatic
apolipoprotein B triglyceride exporting protein (ApoB100)
displayed a severe 5-fold reduction in asparaginase-treated
Gcn2/mice only (Fig. 1F).
Although sex differences were observed in body composition
and glucose tolerance to diet-induced obesity there was no sex-
ual dimorphism in measured outcomes following asparaginase
treatment. Therefore, results from males and females were
combined in subsequent biochemical analyses.
Obesity activates PERK in livers of asparaginase-treatedmice
Previously we identified GCN2 as the primary kinase acti-
vated by asparaginase in lean mice, and livers lacking GCN2
showed no eIF2 phosphorylation following 1, 6, or 8 daily injec-
tions (6, 11, 14). However, following onset of diet-induced obe-
sity, asparaginase treatment robustly induced serine 51 phos-
phorylation of the subunit of eIF2 (p-eIF2) in livers ofWTand
Gcn2/ mice (Fig. 2A). To identify the source of p-eIF2 in
Gcn2/ mice we examined phosphorylation of PERK, a
marker of its activation by ER stress (17). We found on average
20-fold increases in p-PERK in asparaginase-treated Gcn2/
livers (Fig. 2B). WT mice treated with asparaginase also dem-
onstrated significant hepatic phosphorylation of PERK (5-
fold increase over saline control), an effect not seen in leanmice
and thus attributed to obese state.
To investigate the interrelationship between GCN2 and
PERK-launched ISR in response to asparaginase-induced
amino acid depletion we examined expression of ISR target
genes. Transcript abundances of some genes (e.g. Asns and
Atf3) were increased by asparaginase similarly in both strains,
whereas other transcripts, tribbles homolog 3 (Trib3),Atf5, glu-
tamyl-prolyl-tRNA synthetase (Eprs), and Chop, failed to be
induced in livers of asparaginase-treated Gcn2/ mice despite
robustPERKphosphorylation (Fig. 2C).These results indicate that
PERK activity cannot fully rescue activation of the ISR by GCN2
and are consistent with the report that the transcriptional signa-
tures elicited by these two eIF2 kinases are distinct (18).
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Asparaginase exposure decreased hepatic glutathione levels
(supplemental Fig. S2D) similarly in both strains, reflecting a
compromised ability to mount antioxidant defenses. On the
other hand, Gadd34 (Ppp1r15), a gene encoding an eIF2 phos-
phatase that functions as a negative regulator of ISR, was not
induced by asparaginase in either strain (Fig. 2C), an effect pos-
sibly related to the reported influence of obesity on reducing
GADD34 abundance (19). Furthermore, caspase-3 cleavage
was also not increased by asparaginase in either strain (Fig. 2D),
consistent with our previous findings in lean mice (6).
GCN2 is required formTORC1 down-regulation in livers of
asparaginase-treated obesemice
Our lab was the first to identify hyperactivation of mTORC1
during amino acid deprivation in Gcn2/ conditions (14, 20).
Genetic overactivation of hepatic mTORC1 reduces hydrogen
Figure 1. ASNase promotes liver steatosis in obesemice. A, body fat accumulation in male and female wild type (WT) and Gcn2/mice after 12 weeks of
an obesogenic diet, assessed bymagnetic resonance imaging. B, glucose clearance inmale and femaleWT andGcn2/mice after 12weeks of an obesogenic
diet.C,bodyweight change inmale and femaleWTandGcn2/mice followingASNaseorPBSexcipient, expressedaspercentof startingbodyweight.D,gross
morphologyof livers from lean andobeseWTandGcn2/mice followingASNaseor PBS. Scale bar is 1 cm. E, triglyceride accumulation in livers fromobeseWT
and Gcn2/mice following ASNase or PBS. F, hepatic ApoB100 and ApoB48 protein abundance in WT and Gcn2/mice assessed by immunoblotting. Left,
representative picture; right, quantitative analysis of the ApoB100 band. Data are mean S.D. *, p 0.05 as compared with respective PBS control (panels A,
C, E, and F) or lean counterparts panel B).
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sulfide (H2S) producing activity, leading to severe pathologies
(21). To determine whether the GCN2-eIF2-ATF4 cascade
functions to down-regulate mTORC1 activity and maintain
H2S production in liver during asparaginase, phosphorylation
levels of ribosomal S6 kinase 1 (S6K1) and eIF4E-binding pro-
tein 1 (4E-BP1) in WT mice were first assessed. In WT mice,
asparaginase significantly reduced the phosphorylation state of
both proteins, whereasGcn2/ livers showedhyperphosphor-
ylation of S6K1 and 4E-BP1 (Fig. 3,A and B). In agreement with
these findings, asparaginase also increased phosphorylation of
Figure 2. Activation of the ISR in the liver of WT and Gcn2/ obese mice treated with ASNase or PBS. A, phosphorylation of eIF2 by immunoblot.
Quantitative analysis of the relative band intensities are indicated for p-(S51)-eIF2. B, phosphorylation of PERK by immunoblot. Quantitative analysis of the
relative band intensities are indicated for p-(T980)-PERK. C, relative hepatic abundancies of ISR transcripts, evaluated by quantitative RT-PCR.D, representative
immunoblot showing asparaginase to not increase caspase 3 cleavage in liver of obesemice. Data aremean S.D. *,p 0.05 as comparedwith respective PBS
control. # marks difference between strains (p 0.05). n.s., no significant differences.
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two downstream targets of S6K1, p-S2448-mTOR and p-S473-
protein kinase B/Akt, in livers of Gcn2/ as compared with
WT mice (Fig. 3, A and B).
Further exploration into the relationship between the ISR
and mTORC1 revealed that in the Gcn2/ mice treated with
asparaginase the levels of p-eIF2 correlated negatively with
hyperphosphorylation of S6K1 (Pearson correlation coeffi-
cient, r  0.67, p  0.01) and 4E-BP1 (Pearson correlation
coefficient for p-4EBP1 versus p-eIF2, r0.55, p 0.05) (Fig.
3C). Furthermore, among the asparaginase-treated Gcn2/
animals, the highest levels of mTORC1 activity corresponded
with early onset of morbidity (circled points in Fig. 3C).
Together, these data suggest that down-regulation ofmTORC1
is a vital part of the liver adaptive response to asparaginase and
is coordinated largely via GCN2.
Analysis of known upstream regulators of mTORC1 activity
showed that activation of mTORC1 in the Gcn2/ asparagi-
nase-treated group was not due to increases in p-T308 Akt or
Figure 3. GCN2 deletion hyperactivates mTORC1 during ASNase treatment of obese mice. Representative images of immunoblots (A) and quantitative
analysis of relativeband intensities (B) for key componentsofmTORC1pathway in the liversofWTandGcn2/mice treatedwithASNaseorPBS.C, scatterplots
of individual data points showing inverse relationships between p-(S51)-eIF2 and p-(T389)-S6K and between p-(S51)-eIF2 and -4E-BP1 in the Gcn2/
ASNase-treated group. Dotted lines represent 95% confidence interval for Pearson’s linear correlation analysis. Circledmarkers demarcate mice that became
prematurely moribund. D, hepatic hydrogen sulfide production as measured by lead acetate method. E, quantitative analysis of Cth and Cbs gene expression
evaluated by quantitative RT-PCR. Data aremean S.D. *, p 0.05 as comparedwith respective PBS control.Means not sharing a letter are different according
to Tukey post hoc when drug X strain interaction was revealed by analysis of variance. n.s., no significant differences.
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reductions in p-T172 AMP-activated protein kinase (AMPK)
(Fig. 3, A and B). Levels of Sestrin2, an ATF4 target and inhib-
itor of mTORC1 activity during leucine deprivation (22),
were also increased by asparaginase in both strains (Fig. 3, A
and B). Next we analyzed the phosphorylation state of Ses-
trin2, which may also influence mTORC1 activity (23).
Asparaginase caused hyperphosphorylation of Sestrin2 in
WT and Gcn2/ mice (Fig. 3, A and B), indicating that
neither the expression nor phosphorylation of Sestrin2 is
sufficient to inhibit mTORC1 upon these stress conditions
in vivo. These results suggest that GCN2 serves as an essen-
tial component required to inhibit hepatic mTORC1 during
asparaginase exposure independent of known upstream reg-
ulators, Akt, AMPK, and Sestrin2.
Finally, maladaptive activation of PERK and mTORC1 in
obese Gcn2/mice treated with asparaginase coincided with
reduced endogenous hydrogen sulfide (H2S) production (Fig.
3D) and reduced mRNA levels of the ATF4 target gene, cysta-
thionase/cystathionine -lyase (Cth), a key H2S producing
enzyme in the transsulfuration pathway (Fig. 3E). No correla-
tion between hydrogen sulfide production and mRNA levels of
another enzyme in the transsulfuration pathway, cystathionine
-synthase (Cbs), was observed (Fig. 3E). Furthermore, p-eIF2
by PERK was not sufficient to rescue H2S production, suggest-
ing a specific role for GCN2 rather than eIF2 phosphorylation
per se.
Loss of hepatic Atf4 in combinationwith asparaginase does
not reduce apolipoprotein B100
Phosphorylation of eIF2 promotes ATF4 synthesis, a key
event driving ISR activation. To address the role of ATF4 fol-
lowing increased p-eIF2 by asparaginase, mice with genetic
ablation of hepatic Atf4 expression (AlbCre Atf4f/f) and their
congenic wild type Cre-negative counterparts (Atf4f/f) were fed
an obesogenic diet. Analyses of body composition during a
12-week feeding of the obesogenic diet revealed that both male
and female AlbCre Atf4f/fmice maintained lean mass and were
resistant to fat accumulation (Fig. 4A, and supplemental Fig. S3,
A and B) despite consuming more food than their wild type
counterparts (supplemental Fig. S3C). Thus, hepatic ATF4
plays an important role in whole body lipid metabolism, depo-
sition, and storage. Assessment of glucose metabolism showed
that genetic ablation of hepaticAtf4 either directly or indirectly
(via resistance to the fat gain) delayed the onset of glucose intol-
erance inmales (Fig. 4B). Females of both strains were resistant
to glucose intolerance development as in the previous cohort of
mice (Fig. 4B).
Asparaginase proved catabolic in all diet-induced obesemice
as evidenced by similar losses in body weight, body fat, and lean
mass (Fig. 4C, and supplemental Fig. S4,A andB). In contrast to
theGcn2/ animals, none of the asparaginase-treated AlbCre
Atf4f/f mice displayed any signs of premature morbidity. Liver
appearance and size relative to body weight, reduction in
hepatic glutathione levels, and lipid accumulation inAtf4f/f and
AlbCre Atf4f/fmice were similar to the first cohort of WTmice
(Fig. 4, D and E, and supplemental Fig. S4, C and D). No disap-
pearance of apolipoprotein B was observed in asparaginase-
treated AlbCre Atf4f/f livers (Fig. 4F), indicating that mainte-
nance of ApoB100 during asparaginase in liver requires GCN2
but not ATF4. Sexual dimorphism was not observed in the
whole body response to chronic asparaginase exposure and so
once again males and females were analyzed together in subse-
quent analyses.
Genetic ablation of hepatic Atf4 does not block asparaginase-
induced ISR
Lean AlbCre Atf4f/f mice were previously characterized in
studies aimed to investigate the role of ATF4 in chemically-
induced ER stress (24). Analysis of obese Atf4f/f and AlbCre
Atf4f/f animals for activation of the hepatic ISR to asparaginase
showed similar induction of p-eIF2 (Fig. 5A), and p-PERK (Fig.
5B) in contrast to the larger increases observed in livers of
Gcn2/mice.
Despite similar eIF2 phosphorylation levels to asparaginase,
AlbCre Atf4f/f livers demonstrated substantial, albeit variable,
changes in gene expression. For example, mRNA levels of
Chop, Atf3, and Trib3 increased tremendously (37-, 67-, and
120-fold, respectively) as compared withAtf4f/fwild type group
(Fig. 5C) or the first experimental cohort of mice (Fig. 2, and ).
Analyses of Chop, Atf3, and Trib3mRNA induction in the Alb-
Cre Atf4f/f asparaginase-treated group revealed strong positive
correlations between the mRNA abundancies (Fig. 5D). Taken
together, these data suggest that ATF4 functions to limit
expression of these genes during asparaginase treatment. Fur-
thermore, asparaginase-induced changes in Atf5, Asns, and
Eprs transcript abundance were unaffected by loss of ATF4
(Fig. 5C), suggesting that transcriptional induction ofmany ISR
target genes can be driven by an auxiliary factor(s) other than
ATF4. Again, no changes inGadd34 expression were observed
in livers from asparaginase-treated obese mice (Fig. 5C), sup-
porting the idea that induction ofGadd34 is impeded by obesity
(19).
ATF4 is necessary for hydrogen sulfide production but not
down-regulation ofmTORC1 by asparaginase
Assessment of H2S production showed that asparaginase
exposure reduced H2S production capacity (Fig. 6A). Loss of
hepatic Atf4 also reduced overall H2S levels, in agreement with
studies reporting that Cth is a target gene of ATF4 (25). More-
over hepatic capacity to produce H2S correlated with the
expression ofCth andnotCbsmRNA (Fig. 6B). Thus, the failure
tomaintain H2S production in the liver of asparaginase-treated
Gcn2/ mice is due in part to reduced ATF4-driven gene
expression. In contrast, assessment of mTORC1 signaling in
obeseAtf4f/f andAlbCreAtf4f/fmice revealed similar reductions
in the levels of phosphorylated 4E-BP1, S6K1 (Thr-389),mTOR
(Ser-2448), and Akt (Ser-473) upon asparaginase (Fig. 6, C
and D). Analysis of upstream regulators of mTORC1 activity
showed decreased phosphorylation of Akt (Thr-308) upon
asparaginase, whereasAMPKphosphorylation remained stable
(Fig. 6, C and D). Expression and phosphorylation of Sestrin2
was increased by asparaginase in both strains (Fig. 6, C and D).
Taken together, these results suggest that asparaginase reduces
mTORC1 independent of ATF4.
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Discussion
Maladaptive activation of the ISR and deregulation of the
mTORC1 pathway are associated with obesity, hepatic insulin
resistance, and ectopic fat deposition (26–28). Our findings
demonstrate that diet-induced obesity challenges the hepato-
protective capacity of the ISR to amino acid depletion by aspa-
raginase. Moreover, GCN2, the first responder to amino acid
depletion, is required to prevent hyperactivation of mTORC1,
maintain endogenous hydrogen sulfide production, and main-
tain hepatic expression of ApoB100 during asparaginase treat-
Figure 4. ASNase treatment promotes liver steatosis in obese wild type mice (Atf4f/f) and mice deleted for hepatic Atf4 (AlbCre Atf4f/f). A, body fat
accumulation inmale and femalemice after 12weeks of anobesogenic diet, assessedbymagnetic resonance imaging.B,glucose clearance inmale and female
mice after 12weeks of an obesogenic diet.C, total bodyweight loss after 8 days of ASNase or PBS.D,grossmorphology of livers from lean and obesemice after
8 days of ASNase or PBS. Scale bar is 1 cm. E, triglyceride accumulation in livers of obese animals. F, hepatic ApoB protein abundance was assessed by
immunoblotting. Left, representative picture; right, quantitative analysis of the ApoB100 band. Data are mean S.D. *, p 0.05 as compared with respective
PBS control. n.s., no significant differences.
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Figure 5. Activation of the ISR inmice deleted forAtf4 in liver. A, phosphorylation of eIF2 by immunoblot. Representative image and quantitative analysis
of the relative band intensities are indicated for p-(S51)-eIF2. B, phosphorylation of PERK by immunoblot. Representative image and quantitative analysis of
relative band intensities are indicated for p-(T980)-PERK. C, relative abundances of ISR transcripts in livers of obese mice. D, scatter plot showing positive
correlation between Chop and either Atf3 or Trib3.Dotted lines represent 95% confidence interval for Pearson’s linear correlation analysis performed on AlbCre
Atf4f/f ASNase-treated group: Atf3 versus Chop, r 0.81, p 0.05, and Trib3 versus Chop, r 0.83, p 0.05. Data are mean S.D. *, p 0.05 as compared with
respective PBS control (panels A and E) or lean counterparts (panel B). n.s., no significant differences.
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ment. Compensatory activation of PERK fails to provide
for these homeostatic responses in the absence of GCN2.
Our study illuminates how a preexisting metabolic state, in
combination with genetic background, guides hepatic adapt-
ive responses to the amino acid deprivation induced by
asparaginase.
Distinct outcomes following activation of the ISR by aspa-
raginase in obese wild type and Gcn2/ animals emphasize
that each eIF2 kinase elicits distinct cellular response pro-
grams in addition to their shared ability to phosphorylate
eIF2. One of the unique functions attributed to GCN2 is
inhibition of mTORC1 activity during various states of
amino acid deprivation (14, 20, 29, 30). Herein we report
that in response to asparaginase treatment, GCN2 specifi-
cally inhibits hepatic mTORC1 by amechanism independent
of ATF4. This finding is consistent with a recent study of
leucine deprivation in mouse embryonic fibroblasts (30)
demonstrating that GCN2 rapidly inhibits mTORC1 via
Figure6.GeneticablationofhepaticATF4 fails to stimulatemTORC1signalingduringASNase treatment.A,hepaticH2Sproductionasmeasuredby lead
acetatemethod.B,quantitative analysis ofCthandCbsgeneexpression, assessedusingquantitativeRT-PCR.CandD, immunoblot analysis for key components
of mTORC1 pathway: representative images (C) and quantitative analysis of relative band intensities (D). Data are represented as mean S.D. *, p 0.05 as
comparedwith respective PBS control. #marks differencebetween strains (p 0.05).Meansnot sharing a letter are different according to Tukeypost hocwhen
drug x strain interaction was revealed by ANOVA. n.s., no significant differences.
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mechanism(s) requiring phosphorylation of eIF2. Extending
these findings, our study demonstrates that the phosphory-
lation of eIF2 is not sufficient to rescue mTORC1 inhibition
in the absence of GCN2. Thus, inhibition of mTORC1 dur-
ing asparaginase is a unique function of GCN2, distinct from
other eIF2 kinases (Fig. 7).
Exactly how loss of GCN2 unleashes mTORC1 activity dur-
ing asparaginase remains uncertain. Previous reports in combi-
nation with the present findings show that GCN2-mediated
mTORC1 repression is independent of several known up-
stream regulators of mTORC1 activity, namely REDD1, Akt,
and AMPK (11, 14). ATF4-driven negative control of the
mTORC1 pathway during leucine and glutamine deprivation
reportedly occurs via Sestrin2 (22), forming the basis for our
exploration in the current study. However, our findings show
no relationship between Atf4 expression and Sestrin2 protein
levels or its phosphorylation status. Instead, our data suggest
that the pseudokinase TRIB3 may be involved because loss of
Gcn2 but not Atf4 blocked hepatic induction of Trib3 by aspa-
raginase. Studies in cells show TRIB3 to associate with Akt and
suppress the Akt/mTOR axis, and knocking downTrib3 poten-
tiates Akt Ser-473 phosphorylation by growth factors (31–33).
In the current study, asparaginase inhibited Akt Ser-473 phos-
phorylation in wild type,Atf4f/f, andAlbCre Atf4f/fmice but not
Gcn2/ mice. Thus, loss of TRIB3 induction may allow for
dysregulation of the Akt/mTORC1 axis upon asparaginase.
Future studies aimed to directly examine the role of TRIB3
in regulating mTORC1 signaling during asparaginase are
warranted.
The capacity of the liver to produce hydrogen sulfide and
maintain glutathione levels are essential for the organ health
(34, 35). In our diet-induced obesitymodel, loss ofGcn2 orAtf4
maximally reduced endogenous hydrogen sulfide production
during chronic asparaginase treatment. Hydrogen sulfide pro-
duction correlates closely with the expression of Cth, an ATF4
target gene. Physiological role of hydrogen sulfide production
during chronic ER stress has been studied in mouse embryonic
fibroblast cell culture models utilizing thapsigargin, a chemical
inducer of ER stress (36). The study reports that hydrogen sul-
fide production is triggered by chronic ER stress and leads to
specific covalent modification (sulfhydration) of a number of
metabolic enzymes to promote switching of cellular metabo-
lism from oxidative phosphorylation to glycolysis. In the cur-
rent study, we do not see increases in hydrogen sulfide produc-
tion upon asparaginase exposure despite PERK activation in all
strains. We interpret these findings to mean that endogenous
production in liver during asparaginase requires the GCN2-
eIF2-ATF4 axis, in line with the findings by others (10, 35). The
combination of reduced H2S capacity of liver during asparagi-
nase when combined with hyperactivation of mTORC1, a
known instigator of mitochondria function (37, 38), may result
in an energy crisis and metabolic catastrophe, outcomes con-
sistent with premature morbidity in Gcn2/mice.
Asparaginase is one in a growing class of GCN2-activating
drugs (39–47). Our study identifies metabolic state as an
important determinant of hepatoprotection during ISR activa-
tion by amino acid depletion. Furthermore, we identify GCN2
as a master regulator of mTORC1 that acts in an ATF4- and
Sestrin2-independent manner. Moreover, our study demon-
strates that genetic deletion of hepatic Atf4 does not abolish
expression of known ATF4 target genes, namely Trib3, Chop,
and Atf3. Instead, these genes were induced to unprecedented
levels, implying that ATF4 acts as a molecular rheostat, self-
limiting the intensity of the ISR. This study provides novel
information to help prevent or mitigate asparaginase-induced
hepatotoxicity and will assist in the development of metabolic
precision medicine (48).
Experimental procedures
Animals
All animals received humane care according to the criteria
outlined in the “Guide for the Care and Use of Laboratory
Animals” prepared by the National Academy of Sciences and
published by the National Institute of Health (NIH pub-
lication 86–23 revised 1985) and ARRIVE (articulated at
www.nc3rs.org.uk/ARRIVE). Animal protocols were reviewed
and approved by The Rutgers Institutional Animal Care and
Use Committee. Adult (10–20 weeks old) C57Bl/6J wild type
(WT), Gcn2/ (49), Atf4f/f, and AlbCre Atf4f/f mice of both
sexes were provided free access to food (5001 Laboratory
Rodent Diet, LabDiet) and water and maintained on a 12-h
light-dark cycle (7 a.m./7 p.m.) with same sex littermates until
the experimental group assignment wherein mice were housed
in individual plastic cages. Cages contained soft bedding and
enrichment. The Atf4f/f strain was generated as described in
Ref. 50 with loxP sites flanking the second and third exons of
Atf4 gene. The AlbCre Atf4f/f strain was generated by mating
Atf4f/f mice to the mice bearing Cre-recombinase under albu-
min promoter allowing for liver-specific excision of the loxP
flanked region in the offspring. All strains were on C57Bl/6J
background for 8–10 generations.
Diet-induced obesity and assessment of glucose tolerance
All animals were fed a high-fat diet (20% protein, 20% carbo-
hydrate, 60% fat/mostly lard; Research Diets Inc., D12492, NJ)
ad libitum for 15 weeks. Food intake and body weight were
monitored twice a week. Body composition was assessed by
magnetic resonance imaging. At week 12, blood glucose was
measured in conscious animals fasted for 6 h (8:30 amuntil 2:30
pm) in wire-bottom cages with free access to water. Glucose
was administered orally by gavaging 20% glucose solution in the
amount of 2 g/kg of leanmass; blood glucose concentrationwas
measured 15, 30, 60, and 120 min following gavage.
Figure 7. Model depicting molecular signaling during asparaginase
treatment in obese animals. Under conditions of amino acid deprivation,
GCN2 inhibits mTORC1-driven anabolic processes independently of phos-
phorylation of eIF2.
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Injections and sample collection
After 15 weeks of feeding obesogenic diets, animals were
assigned to eight daily (9:00 am) intraperitoneal injections of
either asparaginase (3 IU/g body weight, Elspar, Merck) or
PBS excipient. Treatment assignment was based on total
fat accumulation and glucose tolerance so that treatment
groups were similar in this regard. Animals were killed by
decapitation 8 h following the final injection. Whole
organs were rapidly dissected, weighed, and frozen in liquid
nitrogen.
Liver triglycerides
Triglycerides were measured as described in Ref. 51 with
minor modifications. Briefly, 20–30 mg of the frozen tissue
powder was mixed with 0.4 ml of 1 PBS, 10 mM EDTA
buffer. The resulting mixture was transferred to a screw cap
glass tube containing 2 ml of hexane:isopropyl alcohol (1:4)
solvent and incubated at room temperature for 10 min with
periodic vortexing. Then 0.5 ml of hexane:diethyl ether (1:1)
solvent was added to the glass tubes and the samples were
incubated at room temperature for another 10 min with pe-
riodic vortexing. Then the samples were centrifuged (1,000–
2,000 g for 1 min) to facilitate phase separation and collect
tissue debris at the bottom of the tube. Upper organic phase
containing all the triglycerides extract from the tissue was
transferred to a fresh screw cap glass tube and used to mea-
sure the amount of the triglycerides. Specifically, aliquots of
the organic phase were first dried in the Savant SpeedVac
concentrator equipped with a vapor trap and then assayed
using Infinity TG reagent (Thermo Scientific number
TR22421). Triglyceride amounts were calculated and re-
ported as mg/g of tissue. Standard curve was generated using
corn oil with the assumption that it has density of 0.92 g/cm3.
The corn oil was dissolved in hexane:isopropyl alcohol (4:1)
solvent. Aliquots containing the amount of corn oil that are
within the sensitivity range of the Infinity TG reagent were
transferred to glass tubes, dried, and assayed in the same man-
ner as the samples.
Hydrogen sulfidemeasurement
Hydrogen sulfide production was detected by lead acetate
method (35). Briefly, 50 mg of flash frozen livers were
homogenized in Passive Lysis Buffer (Promega). The lysates
were freeze/thawed three times to facilitate homogenization
and subsequently cleared by centrifugation. Protein concen-
trations were determined via bicinchoninic acid assay
(Thermo Scientific). The hydrogen sulfide production reac-
tion was set up in a 96-well plate by combining 100 l of a
reaction buffer (1 PBS supplemented with 10 mM L-cys-
teine and 1 mM pyridoxal 5	-phosphate) with 20 l of the
liver lysate, containing 5 g of protein/l in each well. A
piece of lead acetate paper was secured on top of the 96-well
plate with a 0.5-kg block weight. The reaction was carried
out at 37 °C for 1 h. Detection of hydrogen sulfide was per-
formed by quantification of dark spots of lead sulfide that
formed on the paper during the reaction time. Densitometry
was carried out using ImageJ software.
Hepatic glutathionemeasurement
Hepatic glutathione was measured in frozen powdered livers
and Bioxytech GSH/GSSG-412 kit for colorimetric determina-
tion of reduced and oxidized glutathione (Percipio Biosciences
number 21040) according to the manufacturer’s instructions.
Quantitative RT-PCR analysis
RNA was isolated from 20 mg of frozen tissue powder using
TRI Reagent according to themanufacturer instructions. Qual-
ity of the isolated RNA was assessed by measuring A260/280 and
A260/230 ratios; integrity was assessed by visualization of the
rRNAon agarose gel. Onemicrogram of the isolated RNA from
each sample was used to generate cDNA using High-Capacity
cDNA Reverse Transcription Kit (Thermo Fisher, 4368814).
The resulting cDNA was used for quantitative analysis of gene
expression using the SYBR Green system. Primers used in this
work are the following: Asns (forward, 5	-CTGTTACAATGG-
TGAAATCTACAACCACAAG-3	 and reverse, 5	-GATGAA-
TGCAAACACCCCGTCCAGCATACAGAT-3	);Ddit3/Chop
(forward, 5	-GAAGCCTGGTATGAGGATCTGCAGGAGG-
TC-3	 and reverse, 5	-CTTTGGGATGTGCGTGTGACCTC-
TGTTG-3	); Ppp1r15a/Gadd34 (forward, 5	-CTTCGACTG-
CAGAGGCGGCTCAGATTG-3	 and reverse, 5	-GAAA-
TGGACTGTGACTTTCTCAGCGAAGTGTAC-3	); Atf3
(forward, 5	-CTGGAGATGTCAGTCACCAAGTCTGAG-3	
and reverse, 5	-CTCCAGTTTCTCTGACTCTTTCTGCAG-
GCAC-3	); Eprs (forward, 5	-TGTGGGGAAATTGACTG-
TGA-3	 and reverse, 5	-AACTCCGACCAAACAAGGTG-3	)
gene expression. Gapdh (forward, 5	-GACAACTCACTCAA-
GATTGTCAGCAATGC-3	 and reverse, 5	-GTGGCAGTGA-
TGGCATGGACTGTGGTC-3	) gene expression was used to
normalize SYBR Green measured mRNA amounts. TaqMan
probes were used to measure transcript abundancies of
Atf5 (Mm04179654_m1), Cth (Mm00461247_m1), and Cbs
(Mm00460654_m1) genes.
Immunoblot analysis
Liver tissue was crushed using the Cellcrusher tissue pulver-
izer under liquid nitrogen conditions. Resulting tissue powder
was lysedwith RIPAbuffer (25mMHEPES, pH7.5, 10mMDTT,
0.1% SDS, 1 protease inhibitormixture (Sigma), 1mM sodium
orthovanadate, 0.5% deoxycholate, 50mM-glycerophosphate,
2 mM EDTA, 1 mM microcystin, 50 mM NaF, 3 mM benzami-
dine) using the Polytron benchtop homogenizer followed by
heating the lysates for 5min in Laemmli buffer. Apolipoprotein
B was resolved on 3–20% gradient gel, Sestrin2 phosphoryla-
tionwas analyzed using 7.5% gel as described inRef. 23. Primary
antibodies used were: anti-total p70S6K (CST 9202), anti-p-
(T389)-S6K (CST 9205), and anti-4E-BP1 (Bethyl Laboratories,
A300–501A), anti-p-(s2448)-mTOR (CST 2971), anti-mTOR
(CST 2972), anti-p-(S51)-eIF2 (CST 3597), anti-eIF2 (sc-
11386), anti-p-(T308)-Akt (CST 9275), anti-p-(S473)-Akt
(CST 9271), anti-Akt (CST 9272), anti-p-(T172)-AMPK (CST
2535), anti-Caspase 3 (CST 9662). Secondary antibodywas per-
oxidase AffiniPure goat anti-rabbit TgC (HL) from Jackson
ImmunoResearch (111-035-003). Imageswere takenwith Fluo-
rchem M imager (ProteinSimple), band densities were quanti-
fied using AlphaView software.
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